2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$91.00+$1.07 (+1.19%)
Price as of Jun 23, 2026 6:33 PM EDT- $4.4BMarket Cap
- 685.41%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$91.00+$1.07 (+1.19%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $89.93 | ||
Change | +$2.17 (+2.47%) | ||
Open | $88.56 | ||
High | $91.27 | ||
Low | $87.01 | ||
Previous Close | $87.76 | ||
Volume | 929,043 | ||
30-Day Average Volume | 1,928,167 | ||
1-Week Change | 1.92% | ||
1-Month Change | -34.94% | ||
1-Year Change | 685.41% | ||
3-Year Change | 653.81% | ||
5-Year Change | 253.64% | ||
Fundamentals | |||
Shares Outstanding | 48.8M | ||
Total Assets | $410.2M | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.3M | ||
EBIT | $1.6M | ||
EBITDA | $1.6M | ||
Net Working Capital | $375.7M | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | 2,771 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -93 | ||
PEG | N/A | ||
Price/Free Cash Flow | -79 | ||
Price/Operating Cash Flow | -80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue